CASE DISCUSSION
Exploring New Agents For Weight Loss
Presented United Arab Emirates by Dr. Yanal SalamViews
4,034
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Case Summary
- Obesity is now recognized as a complex, chronic disease with various complications, necessitating a multidisciplinary approach involving physicians and dietitians. Weight loss medications, such as GLP-1 agonists and GIPs (Monjaro, Wegovy, Ozempic), are increasingly popular, aiming to mitigate complications like type 2 diabetes, asthma, and fatty liver disease.
Speaker Profile
Dr. Yanal Salam
Head of Internal Medicine Department, Emirates Hospital, Jumeirah, Dubai, United Arab EmiratesDisclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.